GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | - | - | - | - | ₹0.02 Cr |
What is the latest Total Debt ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | ₹0.02 Cr |
How is Total Debt of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | -100.00 | |
| Mar2021 | ₹0.02 Cr | - | |
Compare Total Debt of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹39,752.3 Cr | -0.5% | -10.1% | -17.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -0.5% |
-10.1% |
-17.6% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses